Pfizer Inc (NYSE:PFE)

35.00
Delayed Data
As of Mar 30
 +0.47 / +1.36%
Today’s Change
27.51
Today|||52-Week Range
35.45
+12.36%
Year-to-Date
3 Stocks Improving Performance Of The Drugs Industry
Mar 30 / TheStreet.com
3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary
Mar 23 / Zacks.com
Healthcare sector leads feverish M&A activity
Mar 30 / FT.com
This Market Could Grow 6250% in 10 Years
Mar 23 / MotleyFool.com
Hospira Presents Data on Retacrit, an Epogen Biosimilar - Analyst Blog
Mar 30 / Zacks.com
3 Big Pharma Stocks Wall Street Is Wrong About
Mar 23 / MotleyFool.com
Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Y...
Mar 28 / MotleyFool.com
US companies sell record euro debt
Mar 22 / FT.com
3 Little-Known Biotechs Working On Potential Blockbusters
Mar 28 / MotleyFool.com
1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
Mar 22 / MotleyFool.com
Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
Mar 28 / MotleyFool.com
Apple and Google stake a claim to big pharma's turf
Mar 22 / FT.com
Biotech, Chips Stand Their Ground
Mar 27 / TheStreet.com
80% of American Adults Will Suffer From This at Some Point in Their Lives
Mar 21 / MotleyFool.com
19 stocks to buy now
Mar 27 / CNNMoney.com
Why Pfizer Inc. Isn't Built to Last
Mar 21 / MotleyFool.com
3 Stocks Reiterated As A Buy: PFE, LLY, AA
Mar 26 / TheStreet.com
Pfizer Announces Publication of CAPiTA Data on Prevenar 13 - Analyst Blog
Mar 19 / Zacks.com
Should Investors Toss in the Towel on Amarin Corp Plc?
Mar 26 / MotleyFool.com
The charity that matches surplus medicine with acute need
Mar 19 / FT.com
3 Biotech Stocks That Dropped Yesterday -- Is 1 a Buy?
Mar 26 / MotleyFool.com
Veeva Picked as CRM Partner by GlaxoSmithKline, Stock Up - Analyst Blog
Mar 18 / Zacks.com
Pfizer (PFE) Is The 'Chart of the Week'
Mar 25 / TheStreet.com
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
Mar 17 / Zacks.com
4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary
Mar 25 / Zacks.com
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
Mar 17 / Zacks.com
Lpath (LPTN) Crumbles on Failure of Kidney Cancer Drug Trial - Analyst Blog
Mar 25 / Zacks.com
Stock Market News for March 17, 2015 - Market News
Mar 17 / Zacks.com
Is It Time for GlaxoSmithKline plc to Change Management?
Mar 25 / MotleyFool.com
Dementia research boosted by $100m venture capital fund
Mar 16 / FT.com
Pfizer Getting Money Flow
Mar 25 / TheStreet.com
Google-backed genetic testing company hires veteran scientist
Mar 12 / FT.com
Facebook Inc (FB): Catalysts Driving The Stock
Mar 24 / Investing Channel
Going the extra mile to win a B#21bn deal
Mar 06 / FT.com
Pfizer & Eli Lilly to Resume Phase III Study of Tanezumab - Analyst Blog
Mar 24 / Zacks.com
Landmarks on a journey to uncertainty
Mar 06 / FT.com
Pfizer Reveals Detailed Xeljanz Data from Psoriasis Study - Analyst Blog
Mar 23 / Zacks.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account